Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Lung Cancer

Free Subscription Articles published in Am J Respir Crit Care Med Retrieve available abstracts of 55 articles: HTML format

Single Articles

September 2026
1. MURPHY NR, Triplette M, Adams SV, Rustagi AS, et al
   Outcomes of lung cancer screening in a nation-wide cohort of people with HIV compared to without HIV.
   Am J Respir Crit Care Med. 2026 Sep 10:aamag448. doi: 10.1093.
   PubMed    
   
   
   July 2026
2. SCHWARTZ J, Murn M, Laniado I, Studts JL, et al
   Tool In Lesion- But Still Off Target: A Call of Concern for Lung Cancer Screening.
   Am J Respir Crit Care Med. 2026 Jul 27:aamag393. doi: 10.1093.
   PubMed    
   
   
   
3. ZHOU J, Xie X, Zhou C
   Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.
   Am J Respir Crit Care Med. 2026 Jul 23:aamag379. doi: 10.1093.
   PubMed    
   
   
   
4. MENG F, Xia Z, Wang S, Wang Q, et al
   Reply to Zhou et al.: Hypoxic Niche as an Early Determinant of EGFR-Mutant Lung Cancer Progression: Implications for Detection, Intervention, and Subtype-Specific Responses.
   Am J Respir Crit Care Med. 2026 Jul 23:aamag380. doi: 10.1093.
   PubMed    
   
   
   
5. SHIJUBO N, Sumi T, Sugita S, Arioka K, et al
   Cryobiopsy Reveals the Architectural Maturity of Tertiary Lymphoid Structures in Lung Cancer.
   Am J Respir Crit Care Med. 2026 Jul 11:aamag367. doi: 10.1093.
   PubMed    
   
   
   
6. XIE N, Zhao M, Chen F, Zhao Y, et al
   Reply to Wang et al.: Potential biases in trans-omics gene-smoking interaction analyses of lung cancer.
   Am J Respir Crit Care Med. 2026 Jul 10:aamag361. doi: 10.1093.
   PubMed    
   
   
   
7. WANG K, Fu S, Xiang P, Xie L, et al
   Potential biases in trans-omics gene-smoking interaction analyses of lung cancer.
   Am J Respir Crit Care Med. 2026 Jul 10:aamag360. doi: 10.1093.
   PubMed    
   
   
   June 2026
8. PAPAVASSILIOU KA, Stravopodis DJ, Gogou VA, Papavassiliou AG, et al
   Cracking the code of immunotherapy resistance in small cell lung cancer: molecular insights and emerging solutions.
   Am J Respir Crit Care Med. 2026;212:1100-1114.
   PubMed     Abstract available
   
   
   May 2026
9. NANA-SINKAM P
   Toward Precision in Lung Cancer: Screening, Susceptibility, and Therapeutic Resistance.
   Am J Respir Crit Care Med. 2026 May 4:aamag228. doi: 10.1093.
   PubMed    
   
   
   April 2026
10. FUCITO LM, Rojewski AM, Tanoue L, Bernstein SL, et al
    NRT Starter Packs and Gain-Framed Messages to Promote Smoking Cessation in Lung Cancer Screening: A Randomized Trial.
    Am J Respir Crit Care Med. 2026 Apr 24:aamag188. doi: 10.1093.
    PubMed    
    
    
    
11. MANSOURI S, Pullamsetti SS, Savai R
    Spatial niches shape early oncogene-driven lung cancer: Anatomy as destiny.
    Am J Respir Crit Care Med. 2026 Apr 15:aamag195. doi: 10.1093.
    PubMed    
    
    
    
12. WILLIAMS RM
    Beyond Age and Pack-Years: Consideration of Alternative Criteria to Identify Asian-Americans for Lung Cancer Screening.
    Am J Respir Crit Care Med. 2026 Apr 10:aamag192. doi: 10.1093.
    PubMed    
    
    
    March 2026
13. MENG F, Xia Z, Wang S, Wang Q, et al
    Hypoxic niche drives lineage imbalance and early tumorigenesis in EGFR-mutant lung cancer.
    Am J Respir Crit Care Med. 2026 Mar 25:aamag150. doi: 10.1093.
    PubMed     Abstract available
    
    
    
14. CHOI E, Shusted C, Yang H, Evans H, et al
    Impact of Race and Acculturation on Lung Cancer Screening Eligibility: A Multi-Center Lung Cancer Cohort Study.
    Am J Respir Crit Care Med. 2026 Mar 19:aamag134. doi: 10.1093.
    PubMed    
    
    
    
15. CHENG DO, Yamada D, Azimbagirad M, Bhamani A, et al
    Expanded detection of early fibrotic phenotypes using lobar traction bronchiolectasis in lung cancer screening.
    Am J Respir Crit Care Med. 2026 Mar 10:aamag104. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2026
16. WAQAS A, Rasool G, Schabath MB
    Trans-omics Gene-Smoking Interactions: A New Framework for Stratifying Smoking-Related Lung Cancer Risk.
    Am J Respir Crit Care Med. 2026 Feb 25:aamag094. doi: 10.1093.
    PubMed    
    
    
    
17. GHOLAMI M, Vaezi A, Firouzi A, Banoei MM, et al
    Microplastic Accumulation in the Human Lung: Distinct Signatures in Lung Cancer vs Normal Tissue.
    Am J Respir Crit Care Med. 2026 Feb 21:aamag081. doi: 10.1093.
    PubMed    
    
    
    
18. KASHIZAKI F, Oouchi M, Watanabe S, Shonai S, et al
    Lung Cancer with MET Exon 14 Skipping Mutation Presenting with a Crazy-Paving Appearance.
    Am J Respir Crit Care Med. 2026 Feb 15:aamag036. doi: 10.1093.
    PubMed    
    
    
    January 2026
19. XIE N, Xu X, Wang Y, Wang A, et al
    A trans-omics gene-smoking interaction study of lung cancer based on consortium data.
    Am J Respir Crit Care Med. 2026 Jan 23:aamaf097. doi: 10.1093.
    PubMed     Abstract available
    
    
    
20. PENG F, Wang S, Jiao H, Dang M, et al
    Accurate and early diagnosis of non-small cell lung cancer using aberrant fragmentomic features of circulating cell-free mitochondrial DNA.
    Am J Respir Crit Care Med. 2026;212:105-116.
    PubMed     Abstract available
    
    
    October 2025
21. OSTRIN E
    Fragments of a Story: Could Mitochondrial DNA Fragmentomics Upend Lung Cancer Early Diagnosis?
    Am J Respir Crit Care Med. 2025 Oct 22. doi: 10.1164/rccm.202508-1874.
    PubMed    
    
    
    September 2025
22. PAEZ R, Lentz RJ, Duke JD, Siemann JK, et al
    Robotic versus Electromagnetic Bronchoscopy for Peripheral Pulmonary Lesions: A Randomized Trial (RELIANT).
    Am J Respir Crit Care Med. 2025;211:1644-1651.
    PubMed     Abstract available
    
    
    August 2025
23. MADRIGAL JM, Fisher JA, Pruitt CN, Liao LM, et al
    Reply to Zhou et al.: Methodological Pitfalls Undermine Industrial Emission-related Lung Cancer Risk Assessment.
    Am J Respir Crit Care Med. 2025 Aug 22. doi: 10.1164/rccm.202507-1584.
    PubMed    
    
    
    
24. ZHOU D, Wang H, Xiaoli Z
    Methodological Pitfalls Undermine Industrial Emission-related Lung Cancer Risk Assessment.
    Am J Respir Crit Care Med. 2025 Aug 22. doi: 10.1164/rccm.202506-1451.
    PubMed    
    
    
    May 2025
25. GARSHICK E
    Lung Cancer and the Environment.
    Am J Respir Crit Care Med. 2025.
    PubMed    
    
    
    April 2025
26. MADRIGAL JM, Fisher JA, Pruitt CN, Liao LM, et al
    Carcinogenic Industrial Air Emissions and Lung Cancer Risk in a Cohort of 440,000 Americans.
    Am J Respir Crit Care Med. 2025.
    PubMed     Abstract available
    
    
    February 2025
27. SHOJAEE S, Nana-Sinkam P
    Targeting Air Pollution and Reduction in Lung Cancer Incidence and Mortality.
    Am J Respir Crit Care Med. 2025 Feb 19. doi: 10.1164/rccm.202501-0061.
    PubMed    
    
    
    
28. WAMBACH JA, Nogee LM, Spielberg DS, Cole FS, et al
    Interstitial Lung Disease and Lung Cancer Associated with a Monoallelic Novel Variant in SFTPB.
    Am J Respir Crit Care Med. 2025 Feb 19. doi: 10.1164/rccm.202412-2411.
    PubMed    
    
    
    
29. HENDERSON LM, Kim RY, Tanner NT, Tsai EB, et al
    Lung Cancer Screening and Incidental Findings: A Research Agenda. An Official American Thoracic Society Research Statement.
    Am J Respir Crit Care Med. 2025 Feb 10. doi: 10.1164/rccm.202501-0011.
    PubMed     Abstract available
    
    
    
30. KOSTER KM, Feinberg A, Sigel K, Wisnivesky J, et al
    Real-World Smoking History Documentation and Identification of Lung Cancer Screening Candidates.
    Am J Respir Crit Care Med. 2025 Feb 7. doi: 10.1164/rccm.202406-1173.
    PubMed    
    
    
    
31. ZHU M, Han Y, Mou Y, Meng X, et al
    Long-Term Fine Particulate Matter Exposure on Lung Cancer Incidence and Mortality in Chinese Nonsmokers.
    Am J Respir Crit Care Med. 2025 Feb 7. doi: 10.1164/rccm.202408-1661.
    PubMed     Abstract available
    
    
    October 2024
32. LEE YC, Chang KY, Mirsaeidi M
    Associations of Social Determinants and Community Resilience with Lung Cancer Incidence and Mortality in the US.
    Am J Respir Crit Care Med. 2024 Oct 17. doi: 10.1164/rccm.202404-0798.
    PubMed    
    
    
    
33. WYSS N, Berner F, Walter V, Jochum AK, et al
    Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint Blockade.
    Am J Respir Crit Care Med. 2024;210:919-930.
    PubMed     Abstract available
    
    
    
34. PENG C, Talreja J, Steinbauer B, Shinki K, et al
    Discovery of Two Novel Immunoepitopes and Development of a Peptide-based Sarcoidosis Immunoassay.
    Am J Respir Crit Care Med. 2024;210:908-918.
    PubMed     Abstract available
    
    
    August 2024
35. SANTIBANEZ V, Salvatore M, Padilla M
    Late to the Game: Cancer Screening Guidelines and Nodule Surveillance in Idiopathic Interstitial Pneumonias.
    Am J Respir Crit Care Med. 2024;210:390-391.
    PubMed    
    
    
    
36. MOGHADDAM SJ, Document S, Savai R, Salehi-Rad R, et al
    Premalignant Progression in the Lung: Knowledge Gaps and Novel Opportunities for Interception of Non-Small Cell Lung Cancer. An Official American Thoracic Society Research Statement.
    Am J Respir Crit Care Med. 2024 Aug 8. doi: 10.1164/rccm.202406-1168.
    PubMed     Abstract available
    
    
    
37. TEY AJ, Wong JJJ, Lim NF, Ho S, et al
    Systemic Air Embolism after Image-guided Percutaneous Biopsy of the Lung.
    Am J Respir Crit Care Med. 2024;210:e1-e2.
    PubMed    
    
    
    May 2024
38. SAYADI A, Debray MP, Mordant P, Dupin C, et al
    Diffuse Pulmonary Neuroendocrine Cell Hyperplasia with Parietal Pleural Involvement.
    Am J Respir Crit Care Med. 2024;209:1258-1260.
    PubMed    
    
    
    March 2024
39. GONZALEZ AV, Silvestri GA, Korevaar DA, Gesthalter YB, et al
    Assessment of Advanced Diagnostic Bronchoscopy Outcomes for Peripheral Lung Lesions: A Delphi Consensus Definition of Diagnostic Yield and Recommendations for Patient-centered Study Designs. An Official American Thoracic Society/American College of Ch
    Am J Respir Crit Care Med. 2024;209:634-646.
    PubMed     Abstract available
    
    
    February 2024
40. GUPTA N, Johnson SR
    Lymphangioleiomyomatosis: No Longer Ultra-rare.
    Am J Respir Crit Care Med. 2024;209:358-359.
    PubMed    
    
    
    
41. LYNN E, Forde SH, Franciosi AN, Bendstrup E, et al
    Updated Prevalence of Lymphangioleiomyomatosis in Europe.
    Am J Respir Crit Care Med. 2024;209:456-459.
    PubMed    
    
    
    
42. LIN CF, Wu YW, Liao WA, Lin CY, et al
    Right Atrial Angiosarcoma with Embolic Lung Metastases Masquerading as Atypical Pneumonitis.
    Am J Respir Crit Care Med. 2024;209:325-328.
    PubMed    
    
    
    January 2024
43. HALANI V, Sharayah A, Beck B, Patolia S, et al
    "New Targets in Non-Small-Cell Lung Cancer" - RET, HER2 and KRAS.
    Am J Respir Crit Care Med. 2024 Jan 8. doi: 10.1164/rccm.202208-1596.
    PubMed    
    
    
    December 2023
44. HOFFMANN B, Ogurtsova K
    Adding Pieces to the Puzzle - Ultrafine Particles and Lung Cancer.
    Am J Respir Crit Care Med. 2023 Dec 19. doi: 10.1164/rccm.202311-2098.
    PubMed    
    
    
    
45. GOULD MK
    Inappropriate Determinations of Inappropriateness for Lung Cancer Screening.
    Am J Respir Crit Care Med. 2023 Dec 5. doi: 10.1164/rccm.202310-1858.
    PubMed    
    
    
    
46. IKEDA O, Shimizu K, Yamada Y, Sugiura H, et al
    Post-Traumatic Pulmonary Hematoma Presenting as Multiple Ring-shaped Spherical Nodules.
    Am J Respir Crit Care Med. 2023;208:1227-1230.
    PubMed    
    
    
    November 2023
47. STEILING K, Kathuria H
    Occupational Benzene Exposure: An Unrecognized Threat to Lung Cancer Development.
    Am J Respir Crit Care Med. 2023 Nov 29. doi: 10.1164/rccm.202311-2023.
    PubMed    
    
    
    
48. CHAN R, Duraikannu C, Thouseef MJ, Lipworth B, et al
    Larger Mediastinal Lymph Nodes Are Associated with Worse Lung Function in Persistent Asthma.
    Am J Respir Crit Care Med. 2023 Nov 16. doi: 10.1164/rccm.202308-1514.
    PubMed    
    
    
    October 2023
49. JONES RR, Fisher JA, Hasheminassab S, Kaufman JD, et al
    Outdoor Ultrafine Particulate Matter and Risk of Lung Cancer in Southern California.
    Am J Respir Crit Care Med. 2023 Oct 19. doi: 10.1164/rccm.202305-0902.
    PubMed     Abstract available
    
    
    
50. THIBOUTOT J, Pastis NJ, Akulian J, Silvestri GA, et al
    A Multicenter, Single-Arm, Prospective Trial Assessing the Diagnostic Yield of Electromagnetic Bronchoscopic and Transthoracic Navigation for Peripheral Pulmonary Nodules.
    Am J Respir Crit Care Med. 2023;208:837-845.
    PubMed     Abstract available
    
    
    
51. NUNEZ ER, Zhang S, Glickman ME, Qian SX, et al
    What Goes into Patient Selection for Lung Cancer Screening? Factors Associated with Clinician Judgments of Suitability for Screening.
    Am J Respir Crit Care Med. 2023 Oct 11. doi: 10.1164/rccm.202301-0155.
    PubMed     Abstract available
    
    
    
52. WAN W, Peters S, Portengen L, Olsson A, et al
    Occupational Benzene Exposure and Lung Cancer Risk: A Pooled Analysis of 14 Case-Control Studies.
    Am J Respir Crit Care Med. 2023 Oct 9. doi: 10.1164/rccm.202306-0942.
    PubMed     Abstract available
    
    
    
53. LIEBICH A, Enke JS, Reitsam NG, Trepel M, et al
    SSTR Antagonists as Theranostic Option in Small Cell Lung Cancer.
    Am J Respir Crit Care Med. 2023 Oct 4. doi: 10.1164/rccm.202303-0385.
    PubMed    
    
    
    September 2023
54. GRANT-ORSER A, Min B, Elmrayed S, Podolanczuk AJ, et al
    Prevalence, Risk Factors, and Outcomes of Adult Interstitial Lung Abnormalities: A Systematic Review and Meta-Analysis.
    Am J Respir Crit Care Med. 2023;208:695-708.
    PubMed     Abstract available
    
    
    
55. ZHANG T, Hoang PH, Wong JYY, Yang K, et al
    Distinct Genomic Landscape of Lung Adenocarcinoma from Household Use of Smoky Coal.
    Am J Respir Crit Care Med. 2023;208:733-736.
    PubMed    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum